510(k) K221114
K221114 is an FDA 510(k) premarket notification submitted by Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. for the device "Immunoglobulin G (IgG)". The FDA issued a decision of Substantially Equivalent on Aug 2, 2023. The device falls under product code CFN (Method, Nephelometric, Immunoglobulins (G, A, M)), a Class II device regulated under 21 CFR 866.5510. Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 2, 2023
- Date Received
- Apr 15, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Method, Nephelometric, Immunoglobulins (G, A, M)
- Device Class
- Class II
- Regulation Number
- 866.5510
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.